Advertisement


Lawrence H. Einhorn, MD, on CINV Clinical Trial Results: The Alliance A221301 Study

2015 Palliative Care in Oncology Symposium

Advertisement

Lawrence H. Einhorn, MD, of Indiana University Simon Cancer Center, discusses the encouraging study findings on olanzapine for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (Abstract 176).



Related Videos

Palliative Care
Symptom Management

Charles L. Loprinzi, MD, on Olanzapine for Prevention of CINV

Charles L. Loprinzi, MD, of the Mayo Clinic, discusses olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (Abstract 176).

Pain Management

Judith Paice, PhD, RN, on Neuropathic Pain

Judith Paice, PhD, RN, of Northwestern University, reviews the current principles on assessing and treating neuropathic pain in cancer.

Palliative Care
Symptom Management
Lung Cancer

Amelie Harle, MD, on Aprepitant for Cough in Lung Cancer

Amelie Harle, MD, of the Christie NHS Foundation Trust, discusses a clinical trial––the first of its kind—designed to assess the efficacy of an antitussive in patients with lung cancer (Abstract 2).

Palliative Care

Diane Portman, MD, on Integrating Palliative Care in Cancer Treatment

Diane Portman, MD, of Moffitt Cancer Center, discusses clinical pathways that embed palliative care along the spectrum of care for a variety of cancer disease states.

Palliative Care

Kathleen Elizabeth Bickel, MD, MPhil, on Defining High-Quality Palliative Care in Oncology Practice

Kathleen Elizabeth Bickel, MD, MPhil, of the White River Junction VA Medical Center, discusses the ASCO/AAHPM Guidance Statement, which will help oncology providers enhance their delivery of palliative care (Abstract 108).

Advertisement

Advertisement




Advertisement